source
- HHS confirms Americans with high-risk Ebola exposures will have access to experimental therapyAmericans who have high-risk exposures to Ebola in the current outbreak in Central Africa will have access to an experimental antibody treatment.STAT · 1mo ago↗ source
- Otsuka touts new IgAN evidence as it seeks full approval for VoyxactOtsuka Pharmaceutical reported new evidence on Thursday that it thinks will help support a full approval for its monoclonal antibody Voyxact in a chronic autoimmune disease that affects the kidneys…Endpoints · 1mo ago↗ source
- STAT+: Drug companies, patient groups urge FDA to pause commissioner’s voucher programThe White House has used the program to reward companies that help its political goals.STAT · 1mo ago